The number of Covid-19 cases in the United States is currently low but on the rise, according to data from the Centers for Disease Control and Prevention released on Friday.
Infections are particularly noticeable in several states across the Mid-Atlantic, Southeast, and the West Coast. As of July 29, the CDC indicated that in 40 states, infections are “likely to grow,” while nine states have seen no significant change.
The agency reported that while the weekly proportion of emergency department visits for Covid-19 remains low, it’s starting to increase. Most notably, visits among children under four years old are higher, which experts attribute, at least in part, to lower vaccination rates in that age group.
Monitoring through wastewater systems has identified national coronavirus levels as “high” and on the rise.
The CDC also mentioned that currently low levels of coronavirus activity have only been marked as “high” or “very high” in Alabama, Florida, Kentucky, Louisiana, California, Alaska, and Texas.
Experts point out that the lack of comprehensive data makes real-time tracking of Covid-19 challenging, but existing data suggests a seasonal wave is happening, as has been the case in past years.
Historically, Covid-19 peaks have occurred twice a year, with a notable rise in cases during the winter, followed by a decline in spring. Summer typically sees an uptick as people gather indoors to escape the heat.
Other respiratory viruses remain at low levels until winter; however, the mutability of Covid-19 sets it apart, contributing to a notably higher baseline infection rate. This increased circulation of cases can elevate the risk of mutations.
As in previous years, vaccines updated for the upcoming fall season will target the JN.1 variant. Yet, Health and Human Services Secretary Robert F. Kennedy Jr. has significantly limited recommendations on vaccine recipients, stirring questions about accessibility and cost.
In May, Kennedy declared that shots were no longer advised for healthy children, a stance that health experts have challenged, citing a lack of scientific support. A coalition of medical organizations subsequently called for a reevaluation of this policy.
Moreover, the new guidelines stipulate that all updated Covid-19 vaccines must undergo rigorous placebo-controlled trials, treating them as new vaccines instead of just updates to existing ones.
This fall, the updated Covid vaccine is anticipated to be available for adults over 65 and for children and adults with at least one underlying condition, with those groups being exempt from the clinical trial requirements.
